Physician profile
Michael J Singleton
NPI 1013918119
$5,496.79
in general payments reported to CMS, 2019-2025
17 companies · $512 in 2025
The $512 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $432 · 2020: $224 · 2021: $619 · 2022: $1,591 · 2023: $1,303 · 2024: $816 · 2025: $512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,631.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,630.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,752.29 | 2020-2025 | Trelegy Ellipta, Arexvy |
| Lilly USA, LLC | $918.09 | 2019-2025 | Mounjaro, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $445.34 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $345.17 | 2021-2025 | Airsupra, Breztri |
| Pfizer INC. | $334.76 | 2023-2025 | |
| Dexcom, INC. | $271.00 | 2022-2025 | Dexcom G6 Transmitter |
| Amgen INC. | $257.98 | 2023-2025 | Repatha, Repatha, Otezla |
| Novartis Pharmaceuticals Corporation | $254.13 | 2021-2023 | |
| Sanofi-Aventis U.S. LLC | $225.74 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $191.64 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $127.46 | 2022 | |
| Boston Scientific Corporation | $123.56 | 2019 | |
| Xeris Pharmaceuticals, INC. | $83.01 | 2021 | |
| Novo Nordisk INC | $62.35 | 2021-2022 | |
| Medtronic, INC. | $44.61 | 2021-2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linus Health, INC. | $35.01 | 2022 | |
| Scilex Pharmaceuticals INC. | $24.65 | 2023 | Ztlido |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Singleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.